Brain+ at Altenpflege
Brain+ showcased at Danish Dementia Days & Altenpflege in Germany Following the market introduction of the first commercial version of its digital dementia care product, CST Assistant, in Denmark in Q4 2022 and in Germany in Q2 2023, Brain+ has scaled its go-to-market activities. As an essential component, this includes attendance and product showcasing at […]
Second Sales Contract
Brain+ closes its second sales contract for CST Therapist Companion with a dementia care center in Gladsaxe municipality Brain+ announces to have closed a second sales contract for the company’s new digital dementia product, CST – Therapist Companion. The sales contract is a 3-year contract, giving therapists in the municipal dementia care facility, Bakkegården demensboliger, in Gladsaxe access […]
New Digital Health Strategy in Germany
Germany sets a new digitalization strategy further supporting the adoption of digital therapeutics in Europe’s largest healthcare market This month the German Ministry of Health’s shared its new healthcare digitalization strategy, “Gemeinsam Digital”, together with a vision for an integrated digital health ecosystem in Germany. The country’s strong focus on digital solutions represents a great opportunity for Brain+ and other suppliers of digital therapeutics by enabling easier […]
Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine
Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine A key finding from the recently released 2nd systematic Cochrane review (Woods et al., 2023) is the confirmation that medication combined with CST results in significantly larger benefits over and above that of medication alone. More specifically, patients that take part in CST demonstrate […]
EU GRANT
Respected dementia experts and Brain+ get EU grant to research how to optimize digital at-home treatments for people with dementia The EU Joint Programme – Neurodegenerative Disease Research has granted 496,000SEK (or 48,405 euros) to an international research consortium consisting of the University of York Europe Campus, Greece, University of Gothenburg, Sweden, Brain+ A/S, Denmark, […]
New Cochrane review confirms CST
New Cochrane review confirms the benefit and relevance of Cognitive Stimulation Therapy (CST) for people with dementia A 2nd systematic Cochrane review, ‘Cognitive stimulation to improve cognitive functioning in people with dementia’ (Woods et al., 2023), has been published. The systematic review further strengthens the scientific evidence base of CST, the main therapy for dementia that […]
Strong Q4 with Product Launch & Successful Capital Raise
Brain+ announces Investor Webinar following strong Q4 with product launch and succesful capital raise Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful capital raise, and several supportive market news announcements Highlights of Q4 2022 Invitation to Brain+ Q4 investor webinar Brain+ hosts an […]
Pilot with volunteers from DaneAge Association
Brain+ begins commercial pilot with volunteers from the DaneAge Association Brain+, a pioneer in the development of digital therapeutics for Alzheimer’s disease, is excited to announce the launch of a pilot project with DaneAge (Ældre Sagen) to test the use of the Brain+ CST-Therapist Companion to enable volunteers from the association to deliver Cognitive Stimulation Therapy (CST) to […]
Implementation of an ISO 13485 for Medical Devices
Brain+ completes the implementation of an ISO 13485 Quality Management System for Medical Devices Brain+ has successfully completed the implementation of an ISO 13485-compliant Quality Management System (QMS). Such a system helps to set standards to ensure stringent processes throughout every step of a medical device product’s life cycle and thus to maintain a high […]
WHO points to CST to solve the dementia burden
A new WHO report points to Cognitive Stimulation Therapy (CST) and digital solutions As means to help solve the global dementia burden The World Health Organization (WHO) recently published a large report, A blueprint For Dementia Research, as its first initiative of this kind in the context of non-infectious diseases. In the report, WHO refers to […]
